Lung hyperinflation and the risk of fractures in patients with chronic obstructive pulmonary disease
https://doi.org/10.18093/0869-0189-2016-26-3-336-339
Abstract
The purpose of this study was to investigate an association between lung hyperinflation and the risk of bone fracture in patients with chronic obstructive pulmonary disease (COPD).
Methods. The study involved 125 smokers with COPD. The patients treated with systemic steroids were excluded from the study. Lung function and bone mineral density were measured in all the patients. The risk of osteoporotic bone fractures was calculated by FRAX tool.
Results. Lung hyperinflation increased according to the COPD stage. The highest total lung capacity (TLC) was observed in patients with 4 stage COPD (131.43 ± 38.99%pred.) followed by 126.68 ± 21.58%pred. in 3 stage COPD and 115.39 ± 23.68%pred. in 2 stage COPD (p < 0.05). The highest risk of hip fracture (> 3) was calculated for 24.24% of patients with residual lung volume (RV) < 200%pred. and for 45.71% of patients with RV > 200%pred.
Conclusions. The risk of hip fracture was significantly associated with the severity of hyperinflation in COPD patients. The highest risk of fractures was found in patients with 4 stage COPD.
About the Author
E. V. Kochetova
Petrozavodsk State University: 33, Lenina av., Petrozavodsk, Republic of Karelia, Russia
Russian Federation
Russian Federation
PhD, Associate Professor at Department of Hospital Internal Medicine, Petrozavodsk State University; tel.: (8142) 764445
References
1. Avdeev S.N. Pulmonary hypertension in patients with COPD. Prakticheskaya pul'monologiya 2006; 2: 11–16 (in Russian).
2. O′Donnell D.E. Dynamic lung hyperinflation and its clinical implication in COPD. Rev. Mal. Respir. 2009; 26: 19–29.
3. O′Donnell D.E. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006; 3: 180–184.
4. Gatta D., Aliprandi G., Pini L. et al. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Eur. Rev. Med. Pharmacol. Sci. 2011; 15 (9): 1068–1073.
5. Bon J., Fuhrman C.R., Weissfeld J.L. Radiographic emphysema predicts low bone mineral density in a tobaccoexposed cohort. Am. J. Respir. Crit. Care Med. 2011; 183 (7): 885–890.
6. Han M.K., Agusti A., Calverley P.M. et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182 (5): 598– 604.
7. Bon J.M., Zhang Y., Duncan S.R. et al. Plasma inflammatory mediators associated with bone metabolism in COPD. COPD. 2010; 7 (3): 186–191.
8. Kanis J.A., Gluer C.C. For the Committee of Scientific Advisors, International Osteoporosis Foundation. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int. 2000; 11: 192–202.
9. Kanis J.A., Black D., Cooper C. A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis Int. 2002; 3: 527–536.
10. Kanis J.A., Johnell O., Oden A. et al. FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporosis Int. 2008; 19 (4): 385–397.
11. Siminosky K., Leslie W.D., Frame H. et al. Recommendation for bone mineral density reporting in Canada. Can. Ass. Radiol. J. 2005; 56 (3):178–188.
12. Avdeev S.N. Chronic obstructive pulmonary disease as a systemic disorder. Pul'monologiya 2007; 2: 104–116 (in Russian).
13. Bai P., Sun Y., Jin J. et al. Disturbance of the OPG / RANK /RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir. Res. 2011, 12: 157.
14. Ensrud K.E., Thompson D.E., Cauley J.A. et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. J. Am. Geriatr. Soc. 2000, 48: 241–249.
Review
For citations:
Kochetova E.V. Lung hyperinflation and the risk of fractures in patients with chronic obstructive pulmonary disease. PULMONOLOGIYA. 2016;26(3):336-339. (In Russ.) https://doi.org/10.18093/0869-0189-2016-26-3-336-339
Views:
834
Email this article 